Published

Investigating the impact of serotonergic psychedelic drugs, MDMA and ketamine on social cognition in psychiatric disorders: A scoping review.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Psychopharmacology
Date: 2026-07-01
Source: PubMed
DOI: 10.1007/s00213-026-07110-y
PubMed: 42380668

Authors

Smith SA Mohammad H Lee LHN Dennett L Smith S Burback L Winkler O Greenshaw A Jetly R Kennedy SH Bhat V Swainson J Vermetten E Cao B Li XM Zhang Y

Watch author

Derived topics and classifications

psilocybin Depression Anxiety PTSD Emotional Processing Review Article Review Article

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Editorial: Psychedelic-assisted psychotherapies: from clinical trials to credibility.Frontiers in neuroscience · 2026-01-01 Psychedelic-Assisted Psychotherapy for Post-Traumatic Stress Disorder, Anxiety Disorders, Mood Disorders, or Substance Use DisordersCanadian Agency for Drugs and Technologies in Health, Ottawa (ON) · 2021-06-01 Psilocybin and Neuroplasticity: Mechanisms, Therapeutic Potential, and Future DirectionsEmerging Trends in Drugs Addictions and Health · 2025-12-01 Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders.Journal of psychoactive drugs · 2024-01-01 Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders.Journal of psychoactive drugs · 2017-01-01 Psychedelic Assisted Psychotherapy (PAP): the Geneva University Hospital modelEmerging Trends in Drugs Addictions and Health · 2025-12-01 Exploring Jordanian Physicians' and Medical Students' Perspectives on Ketamine and Psychedelic-Assisted Therapies: An Insight from the Middle East.Journal of psychoactive drugs · 2025-07-06 Exploring psilocybin's role in mental health and palliative medicine: a path to improved well-being.Expert opinion on emerging drugs · 2025-06-01